Efficacy of switching from a combination therapy of long-acting somatostatin analogs (LA-SSAs) and pegvisomant to weekly pegvisomant in acromegaly patients
Latest Information Update: 13 Oct 2016
At a glance
- Drugs Pegvisomant (Primary)
- Indications Acromegaly
- Focus Therapeutic Use
- 13 Oct 2016 New trial record